Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7.69M |
$146M |
$19.00 |
Jun 28, 2021 |
Direct |
Korro Bio, Inc. |
10%+ Owner |
Common Stock |
1.09M |
$61.1M |
$56.00 |
Apr 22, 2024 |
Direct |
MBX Biosciences, Inc. |
10%+ Owner |
Common Stock |
3.61M |
$38.6M |
$10.69 |
Sep 16, 2024 |
Direct |
NeueHealth, Inc. |
Director, 10%+ Owner |
Common Stock |
0 |
$0 |
$6.84 |
Oct 2, 2025 |
Direct |
MBX Biosciences, Inc. |
10%+ Owner |
Series A Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Direct |
MBX Biosciences, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Direct |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series A-2 convertible preferred stock |
0 |
|
|
Jun 28, 2021 |
Direct |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series B convertible preferred stock |
0 |
|
$2.00 |
Jun 28, 2021 |
Direct |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series C convertible preferred Stock |
0 |
|
$2.96 |
Jun 28, 2021 |
Direct |
NeueHealth, Inc. |
Director, 10%+ Owner |
Series A Convertible Perpetual Preferred Stock |
0 |
|
|
Oct 2, 2025 |
Direct |
NeueHealth, Inc. |
Director, 10%+ Owner |
Series B Convertible Perpetual Preferred Stock |
0 |
|
|
Oct 2, 2025 |
Direct |
NeueHealth, Inc. |
Director, 10%+ Owner |
Warrant (Right to Buy) |
0 |
|
|
Oct 2, 2025 |
Direct |